معرفی
Anjali Rajadhyaksha, PhD, is a faculty member at the Lewis Katz School of Medicine at Temple University, where she serves as Director of the Center for Substance Abuse Research. Her research focuses on the molecular and genetic underpinnings of substance use and mood-related disorders, with a strong emphasis on translational neuroscience.
Education:
- BSc in Chemistry, University of Mumbai
- PhD in Molecular Biology, Purdue University
- Postdoctoral Fellowship in Molecular Neuroscience, Harvard Medical School
Her research interests lie at the intersection of neuropharmacology and molecular genetics. She investigates how voltage-gated L-type calcium channels (Cav1.2 and Cav1.3) influence cocaine- and mood-related behaviors, leveraging patient data linking CACNA1C and CACNA1D genes to neuropsychiatric conditions. Additionally, she explores how modulating the endocannabinoid system may reduce opioid reward without compromising analgesia. These studies use advanced techniques including genetic models, viral vectors, in vivo calcium imaging, and behavioral assays in defined brain circuits.
No recent articles are listed in the provided text, so no trend analysis can be performed.
Scientific Awards:
- Outstanding Performance as Undergraduate Mentor - The Leadership Alliance
- Weill Cornell Graduate School Excellence in Teaching and Mentoring Award
Dr. Rajadhyaksha is actively involved in mentoring and education, as reflected in her awards. While no specific grants are mentioned, her research program suggests active funding in neuroscience and addiction research. She leads a research laboratory focused on developing therapeutic strategies for drug dependence and co-occurring mood disorders.
She directs the Center for Substance Abuse Research, indicating leadership in a multidisciplinary team focused on addiction science. The center likely involves collaboration across neuroscience, pharmacology, and behavioral research domains.
